-
Posted: March 31st, 2010, 7:00am CDT
The Breast Health Global Initiative (BHGI) and the Latin American & Caribbean Society of Medical Oncology (SLACOM) will convene the fourth biennial BHGI Global Summit on International Breast Health June 9-11, 2010 in Chicago, bringing together collaborating national and international organizations to address the optimization of breast health care delivery in limited-resource countries...
-
Posted: March 31st, 2010, 5:00am CDT
Younger women are likely to attend breast screening if the choice is offered to them, according to the findings of a study of 50,000 women published today in the Journal of Medical Screening...
-
Posted: March 31st, 2010, 5:00am CDT
For every woman overdiagnosed by breast screening , two deaths will be prevented, according to a study published today (Wednesday). Following controversial debates in recent months over the risks and harms of screening for breast cancer , the researchers - part funded by Cancer Research UK - set out to uncover how effective the programme is at saving lives...
-
Posted: March 31st, 2010, 4:00am CDT
In a ruling that could have "far-reaching" implications for genetic research and the medical industry, a U.S. District Judge Robert Sweet on Monday invalidated seven patents related to the BRCA1 and BRCA2 genes, mutations of which have been linked to breast and ovarian cancer, the New York Times reports (Pollack/Schwartz, New York Times, 3/29)...
-
Posted: March 31st, 2010, 4:00am CDT
Following recent controversy about the pros and cons of breast screening, a new study part-funded by Cancer Research UK found that breast screening saves two lives for every case of over-diagnosis. The study by scientists at Wolfson Institute of Preventive Medicine at Barts and the London School of Medicine and Dentistry, is about to be published in the Journal of Medical Screening...
-
Posted: March 31st, 2010, 2:00am CDT
Critical Outcome Technologies Inc. (COTI) (TSX VENTURE:COT) announced positive test results today from a series of animal experiments carried out at a prominent Canadian cancer research facility with COTI-2 as a single agent against an aggressive strain of triple negative human breast cancer (TNBC); MDA-MB-231-luc...
-
Posted: March 30th, 2010, 4:00am CDT
Researchers in Sweden who studied data on over 35,000 middle aged and older women followed for 10 years found a link between taking multivitamins and increased risk of breast cancer and said this was of concern to public health and should be investigated further...
-
Posted: March 30th, 2010, 4:00am CDT
Scientists on Thursday presented new breast cancer research at a conference in Barcelona, Spain. Summaries appear below. ~ Prevention: Twenty-five to thirty percent of breast cancer cases in Western countries could be prevented through diet and exercise, according to study of data from the World Health Organization's International Agency for Research on Cancer, AP/MSNBC reports...
-
Posted: March 30th, 2010, 3:00am CDT
While radiation therapy is common after breast conserving surgery, it's much less frequent after mastectomy, even among women for whom it would have clear life-saving benefit. This is according to a new study from researchers at the University of Michigan Comprehensive Cancer Center...
-
Posted: March 30th, 2010, 2:00am CDT
Expression of inflammatory-related genes in breast tissue of women who have previously given birth may explain the aggressiveness and frequency of pregnancy-associated breast cancer, according to new research at the University of Illinois at Chicago...
-
Posted: March 28th, 2010, 4:00am CDT
Tumors biopsied from women with invasive breast cancer are having their genomes sequenced in an attempt to develop a DNA profile that one day may identify ahead of time the patients who will most likely respond to chemotherapy with an aromatase inhibitor. Aromatase inhibitors are a class of chemotherapeutic agents that block the production of estrogen in postmenopausal women...
-
Posted: March 27th, 2010, 4:00am CDT
Agendia, a world leader in molecular cancer diagnostics, announced that its breast cancer product offering, consisting of breast cancer recurrence test MammaPrint(R), and TargetPrint(TM), has been expanded with BluePrint (TM) to report important additional information on tumor subtypes...
-
Posted: March 27th, 2010, 3:00am CDT
In patients with early breast cancer, giving radiotherapy to the lymph nodes located behind the breast bone and above the collar bone is well-tolerated, after mastectomy or breast conserving surgery, a radiation oncologist will tell delegates at the seventh European Breast Cancer Conference (EBCC7) (Saturday 27 March)...
-
Posted: March 27th, 2010, 2:00am CDT
An international team of researchers has discovered a new way of detecting which breast cancer patients are going to respond best to chemotherapy that includes anthracycline antibiotics*...
-
Posted: March 27th, 2010, 2:00am CDT
Preclinical Model of Primary Prostate Cancer A group led by Dr. Massimo Loda at the Dana Farber Cancer Institute, Boston, MA has generated a preclinical model of human prostate cancer that mimics the genetic and growth behavior of primary tumors. Their report can be found in the April 2010 issue of the American Journal of Pathology...
-
Posted: March 26th, 2010, 11:00am CDT
The presence of the protein poly (ADP-ribose) polymerase (PARP) in tumours can help predict their response to chemotherapy, a German scientist will tell the seventh European Breast Cancer Conference (EBCC7) in Barcelona tomorrow (Saturday 27 March)...
-
Posted: March 26th, 2010, 8:00am CDT
Trends indicate that survival is improving in patients with metastatic breast cancer, especially in those patients whose tumours are described as being HER2 (human epidermal growth factor receptor-2) positive, a surgical oncologist will say today (Friday 26 March) at the seventh European Breast Cancer Conference (EBCC7)...
-
Posted: March 26th, 2010, 8:00am CDT
Two studies to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday) and tomorrow (Saturday), shed light on the treatment options facing women carrying the BRCA1 and BRCA2 genetic mutations which predispose them to breast cancer...
-
Posted: March 26th, 2010, 8:00am CDT
Treatment with beta-blockers can help reduce the spread of cancer in patients with breast tumours, a researcher will tell the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday). In a controlled study, Dr...
-
Posted: March 26th, 2010, 6:00am CDT
Women who discover they have breast cancer while they are pregnant can be treated with chemotherapy without endangering the health of their unborn baby, according to research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday)...
-
Posted: March 26th, 2010, 6:00am CDT
Women who are diagnosed with breast cancer in the 12 months after they have completed a pregnancy are 48% more likely to die than other young women with breast cancer according to new research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday)...
-
Posted: March 26th, 2010, 5:00am CDT
Women who have been diagnosed with breast cancer believe the risk of the disease occurring in their unaffected breast is as much as ten times higher than it actually is. As a result, they are choosing to have prophylactic mastectomies based on a false perception of increased risk, according to new research...
-
Posted: March 26th, 2010, 5:00am CDT
Women who have been treated for breast cancer can choose to become pregnant and have babies, without fears that pregnancy could put them at higher risk of dying from their cancer, according to a major, new study...
-
Posted: March 25th, 2010, 11:00pm CDT
The London Breast Clinic today announced that it is to be the first breast clinic in Europe to offer their patients BCtect®, a blood based test for early detection of breast cancer...
-
Posted: March 25th, 2010, 8:00am CDT
At a time when more and more young women are surviving breast cancer and delaying childbirth, it is important to take their needs and wishes about their future fertility into consideration when deciding on treatment, the seventh European Breast Cancer Conference (EBCC7) in Barcelona heard. Dr...
-
Posted: March 25th, 2010, 8:00am CDT
Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors (SSRIs), prescribed drugs that inhibit the effect of an important enzyme...
-
Posted: March 25th, 2010, 7:00am CDT
The largest study in Europe to look at the link between socioeconomic status and survival after breast cancer has found that women from poorer backgrounds have worse outcomes and that this is only partly explained by more advanced cancer at diagnosis...
-
Posted: March 25th, 2010, 7:00am CDT
Recurrence of breast cancer in the same area as the original tumour remains the strongest, independent prognostic factor for subsequent metastasis and death, even for patients who have been free of disease for a very long time, according to research presented today at the seventh European Breast Cancer Conference (EBCC7)...
-
Posted: March 25th, 2010, 7:00am CDT
Many patients with metastatic breast cancer believe that the primary goal in survival with new treatment should be to prolong life by at least a year over the survival they might expect from using current best therapies, a researcher told the seventh European Breast Cancer Conference (EBCC7) in Barcelona...
-
Posted: March 25th, 2010, 2:00am CDT
Scott & White Healthcare researchers are studying an investigational agent that targets metastatic breast cancer to find if it can stop cancer cells from continuing to grow...
-
Posted: March 24th, 2010, 4:00am CDT
Garnet BioTherapeutics, Inc. ("Garnet"), a regenerative medicine company focused on developing cell based therapies, announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York...
-
Posted: March 24th, 2010, 2:00am CDT
Scientists at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center (GUMC) were awarded a five-year $7.5 million grant to tease apart - in the most comprehensive way ever devised - the role of a single protein receptor in breast cells in cancer development and treatment...
-
Posted: March 23rd, 2010, 8:00am CDT
Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. announced that they have temporarily suspended the clinical program for Stimuvax® (BLP25 liposome vaccine) in all recruiting studies worldwide as a result of a suspected unexpected serious adverse reaction (SUSAR). This decision was taken in alignment with the U.S...
-
Posted: March 23rd, 2010, 4:00am CDT
Testing for 10 common genetic mutations that slightly increase breast cancer risk is no more effective in predicting tumor development than asking women questions about conventional risk factors, according to a study published Wednesday in the New England Journal of Medicine, Reuters/MSNBC reports...
-
Posted: March 22nd, 2010, 3:00am CDT
Certain rare mutations in the ataxia telangiectasia mutated (ATM) gene, combined with radiation exposure, may increase a woman's risk of developing a second cancer in the opposite breast, according to a study published online March 19 in the Journal of the National Cancer Institute...
-
Posted: March 19th, 2010, 7:00am CDT
Although Asian Americans have long been portrayed as a "model minority" with few major problems, data released online in the American Journal of Public Health (AJPH) reveal that distinct groups of Asian Americans, Native Hawaiians and Pacific Islanders (AA and NHPI) differ widely in death and disease rates, including from breast cancer and other conditions such as heart disease...
-
Posted: March 19th, 2010, 4:00am CDT
Research scientists from the Cancer Prevention Institute of California (CPIC) released the results of a study of breast cancer in Asian women which examined their cancer rates by ethnicity, age and immigrant status. The findings challenge the notion that breast cancer rates are uniformly low across the population of Asian women and indicate rising rates of occurrences in specific ethnic groups...
-
Posted: March 19th, 2010, 3:00am CDT
Scientists report that breast cancer risk assessment models, which predict a woman's chance of developing breast cancer, do not perform better when they include common inherited genetic variants recently linked to the disease. Therefore, recommendations for breast cancer screening or treatments will remain unchanged for most women...
-
Posted: March 18th, 2010, 6:00am CDT
Technology never before offered in the U.S. that allows patients to receive one dose of radiation during surgery, as opposed to the current average of six weeks, was successfully delivered to several breast cancer patients last week including the sister of the man responsible for bringing the technology from Italy...
-
Posted: March 18th, 2010, 5:00am CDT
Agendia, a world leader in molecular cancer diagnostics, announced it will participate in the highly anticipated I-SPY 2 TRIAL for breast cancer, set to launch at the first of nearly twenty research sites...
-
Posted: March 17th, 2010, 6:00am CDT
Interventional radiologists have opened the door to an encouraging potential future treatment for the nearly 200,000 women who are diagnosed with breast cancer in the United States each year: image-guided, multiprobe cryotherapy...
-
Posted: March 17th, 2010, 5:00am CDT
Interventional radiologists have opened the door to an encouraging potential future treatment for the nearly 200,000 women who are diagnosed with breast cancer in the United States each year: image-guided, multiprobe cryotherapy...
-
Posted: March 17th, 2010, 4:00am CDT
Case management appears to be associated with more appropriate follow-up and shorter time to diagnostic resolution among low-income women who receive an abnormal result on a mammogram, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Rebecca Lobb, Sc.D., M.P.H., of the Centre for Research on Inner City Health, St...
-
Posted: March 17th, 2010, 2:00am CDT
New research findings published in the March issue of the Journal of the American College of Surgeons indicate that some breast cancers continue to be detected as a palpable lump rather than being found through mammographic screening...
-
Posted: March 16th, 2010, 6:00am CDT
New data from an NIH-sponsored, multi-site study of hundreds of women with newly diagnosed breast cancer shows that Positron Emission Mammography (PEM) may reduce unnecessary breast biopsies...
-
Posted: March 16th, 2010, 5:00am CDT
More than 1,200 operating room nurses attended this morning's breakfast forum "Together We Can Save Lives Through Early Detection" sponsored by Medline Industries, Inc., expecting to hear Olympic gold medalist Peggy Fleming talk about her skating career and battle with breast cancer. Fleming did not disappoint the early morning crowd...
-
Posted: March 15th, 2010, 4:00am CDT
Researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center have discovered that "microtentacles," or extensions of the plasma membrane of breast cancer cells, appear to play a key role in how cancers spread to distant locations in the body...
-
Posted: March 14th, 2010, 1:00am CST
Pfizer Inc. announced today that two Phase 3 studies of Sutent® (sunitinib malate) in advanced breast cancer did not meet their primary endpoints...
-
Posted: March 13th, 2010, 4:00am CST
TechniScan, Inc. (OTC Bulletin Board: TSNI) is featured on NVIDIA's recently posted blog about speeding the amount of time it takes to get breast imaging results into the hands of doctors and patients. NVIDIA is the world leader in visual computing technologies and inventor of the graphics processing unit (GPU)...
-
Posted: March 13th, 2010, 3:00am CST
Many women live with breast cancer that does not respond to standard medical treatment, a condition that researchers at the Virginia G. Piper Cancer Center at Scottsdale Healthcare want to change by aggressively targeting specific genes...
-
Posted: March 13th, 2010, 2:00am CST
Conventional biological wisdom holds that living cells interact with their environment through an elaborate network of chemical signals. As a result many therapies for the treatment of cancer and other diseases in which cell behavior goes awry focus on drugs that block or disrupt harmful chemical signals...
-
Posted: March 12th, 2010, 5:00am CST
Every year more than 100,000 women in the United States undergo a lumpectomy, a conservative procedure to remove cancerous tumors while preserving the breast. The surgeon's goal is to attain a tumor-free, or negative, surgical margin the first time they operate...
-
Posted: March 11th, 2010, 7:00am CST
Recent studies show that more women with cancer in one breast are opting for removal of both breasts, even though removal of the healthy breast does little to improve survival rates, New York Times columnist Tara Parker-Pope writes...
-
Posted: March 11th, 2010, 5:00am CST
Breast cancer continues to rise in Iraq, and scientists have established the Iraqi National Cancer Research Program to better understand the underlying molecular and environmental causes in an effort to curb the incidence of cancer. "Breast cancer is the most common type of malignancy recorded in the cancer registries of almost all countries within the Eastern Mediterranean Region...
-
Posted: March 11th, 2010, 3:00am CST
Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, Indiana University Bloomington scientists report in this month's Cancer Biology & Therapy...
-
Posted: March 11th, 2010, 1:00am CST
Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests for the early and accurate detection of breast cancer. The Chronix tests detect the circulating DNA that is released into the blood stream by damaged and dying cells...
-
Posted: March 10th, 2010, 4:00am CST
TechniScan, Inc. (OTC Bulletin Board: TSNI) ("TechniScan" or the "Company"), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center...
-
Posted: March 10th, 2010, 3:00am CST
What began as research into how diabetics could possibly preserve their eyesight has led to findings that could prolong the vision of children afflicted with retinoblastoma...
-
Posted: March 10th, 2010, 3:00am CST
The Side-Out Foundation, which pairs volleyball enthusiasts with breast cancer researchers, is sponsoring a new clinical trial for up to 25 patients with advanced breast cancer. TGen Drug Development (TD2) will manage this pilot study for the Side-Out Foundation at two locations: TGen Clinical Research Services (TCRS) at Scottsdale Healthcare in Scottsdale, Ariz...
-
Posted: March 9th, 2010, 4:00am CST
Postmenopausal women, including those over 70 years old, who have been newly diagnosed with cancer in one breast have higher cancer detection rates when the other breast is scanned for tumors with MRI, compared to premenopausal women, say researchers at the Mayo Clinic campus in Florida. They found that 3...
-
Posted: March 9th, 2010, 3:00am CST
One in three early stage breast cancer patients who received genomic testing when deciding about treatment options felt they did not fully understand their discussions with physicians about their test results and their risk of the disease recurring, a new study has found...
-
Posted: March 8th, 2010, 7:00am CST
Life Technologies Corporation (NASDAQ:LIFE) announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies...
-
Posted: March 8th, 2010, 6:00am CST
A new study has found that one in three early-stage breast cancer patients who received genomic testing when deciding about treatment options felt they did not fully understand their discussions with physicians about their test results and their risk of recurrence. About one in four experienced distress when receiving their test results...
-
Posted: March 8th, 2010, 4:00am CST
Breast cancer patients with early stage disease that has spread to only one lymph node may not benefit from radiation after mastectomy, because of the low present-day risk of recurrence following modern surgery and systemic therapy, a finding that could one day change the course of treatment for thousands of women diagnosed each year, according to researchers at The University of Texas M. D...
-
Posted: March 8th, 2010, 2:00am CST
Life Technologies Corporation (NASDAQ: LIFE) has announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies...
-
Posted: March 7th, 2010, 2:00am CST
Amber J. Belcher, a doctoral student in psychology at the University of Delaware, has won the Ruth L. Kirschstein National Research Service Award from the National Institutes of Health (NIH). The fellowship will support Belcher's research on how couples cope with breast cancer. Breast cancer is second only to skin cancer as the most common cancer among women in the United States...
-
Posted: March 5th, 2010, 6:00am CST
A new study, led by researchers at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, demonstrates that acupuncture may be an effective therapy for joint pain and stiffness in breast cancer patients who are being treated with commonly used hormonal therapies. Results were published in the Journal of Clinical Oncology...
-
Posted: March 5th, 2010, 4:00am CST
At a recent community education program, Stanford experts on women's cancer disagreed with controversial new federal guidelines on breast cancer screening. The new guidelines, released in November by the U.S. Preventive Services Task Force, would delay a woman's first mammogram by 10 years, reduce future screenings from annual to every other year, and end them after age 74...
-
Posted: March 4th, 2010, 8:00am CST
While breast cancer continues to be the second most common cancer among women in the U.S., "rates have been declining by about 2% a year since 1999, after having increased for the previous 20 years," Newsweek contributing editor Barbara Kantrowitz and Washington correspondent Pat Wingert write in a opinion piece...
-
Posted: March 4th, 2010, 6:00am CST
Older women who have had breast cancer surgery have a greater risk of the cancer returning if they delay their post-surgical radiation treatment, report Dana-Farber Cancer Institute scientists...
-
Posted: March 3rd, 2010, 5:00pm CST
Cancer Research UK re-release 'Girls Just Wanna Have Fun' to launch Race for Life 2010 Hundreds of women from across the UK have joined over 20 celebrities to record a unique charity single in aid of Cancer Research UK's Race for Life...
-
Posted: March 3rd, 2010, 10:00am CST
Women who take some types of bone-building drugs used to prevent and treat osteoporosis may be at lower risk of breast cancer, according to a study by U.S. researchers published today in the British Journal of Cancer...
-
Posted: March 3rd, 2010, 9:00am CST
Freezing a cancer kills it in its place, and also appears to generate an immune response that helps stop the cancer's spread, leading to improved survival rates over surgery, according to a new study in mice from researchers at the University of Michigan Comprehensive Cancer Center...
-
Posted: March 3rd, 2010, 6:00am CST
A new study is providing insight into how estrogen fuels many breast cancers, and researchers say the findings could lead to new cancer-fighting drugs. Researchers found that estrogen inhibits a protein called MLK3 that causes normal cell death. Blocking MLK3 leads to uncontrolled growth of cancer cells and resistance to chemotherapy...
-
Posted: March 3rd, 2010, 6:00am CST
TechniScan, Inc. (OTC Bulletin Board: TSNI) ("TechniScan" or the "Company"), a medical device company engaged in the development and commercialization of an automated 3-D breast ultrasound imaging system, announced that in collaboration with University Medical Center Freiburg in Germany, it has launched a clinical study to assess clinical utility of TechniScan's Warm Bath Ultrasound...
-
Posted: March 3rd, 2010, 5:00am CST
Can a drug that has been used to treat malaria for years possibly be used to treat breast cancer before it becomes invasive? That's what researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove...
-
Posted: March 3rd, 2010, 2:00am CST
A study published on bmj.com today reports that the longer women wait for radiotherapy after breast cancer surgery, the more chance there is of local recurrence. Starting radiotherapy as soon as possible will minimize this risk according to the authors. The reasonable generally accepted interval between cancer surgery and radiotherapy is four to six weeks...
-
Posted: March 2nd, 2010, 7:00am CST
A patient with a breast lump that has no features suggesting cancer should still be immediately evaluated, according to a primer for physicians in CMAJ (Canadian Medical Association Journal) This article provides an "in office" approach for immediate evaluation of women who present to their family physician with a breast lump...
-
Posted: March 2nd, 2010, 7:00am CST
An imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM). The technique enables researchers to visualize tumor activity at the molecular level...
-
Posted: March 2nd, 2010, 5:00am CST
Cancer Research UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology...
-
Posted: March 2nd, 2010, 4:00am CST
The challenges facing young women with breast cancer, and the promise of high-tech cancer care in rural settings, are the subjects of innovative new grants addressing real-life issues in cancer care, awarded by the ASCO Cancer Foundation®, with funding from Susan G. Komen for the Cure®. The $2...
-
Posted: March 2nd, 2010, 3:00am CST
A preventive mastectomy of a healthy breast does not increase survival rates in most women with cancer in the other breast, although the procedure might prolong survival in a specific subset of patients, according to a new study from researchers at MD Anderson Cancer Center, Time reports...
-
Posted: March 2nd, 2010, 2:00am CST
A newly identified cancer biomarker could define a new subtype of breast cancer as well as offer a potential way to treat it, say researchers at Washington University School of Medicine in St. Louis. Their findings will be published in the March 1 online early edition issue of the Proceedings of the National Academy of Sciences...
-
Posted: March 1st, 2010, 4:00am CST
Hypnosis can help alleviate the pain and suffering experienced by women being treated for breast cancer, according to a study by a University at Buffalo School of Social Work professor. The randomized trial measured pain and suffering, frequency of pain and degree of constant pain among 124 women with metastatic breast cancer, according to Lisa D...
-
Posted: March 1st, 2010, 3:00am CST
Metastases that were 2 millimeters or less in diameter ("micrometastases") in axillary lymph nodes detected on examination of a single section of the lymph nodes were associated with poorer disease-free and overall survival in breast cancer patients, according to a new study published online February 26 in the Journal of the National Cancer Institute...
-
Posted: March 1st, 2010, 2:00am CST
Huixin He, associate professor of nanoscale chemistry at Rutgers University, Newark, and Tamara Minko, professor at the Rutgers Ernest Mario School of Pharmacy, have developed a nanotechnology approach that could potentially eliminate the problems of side effects and drug resistance in the treatment of cancer...